As the coming year approaches, more vendors are working toward meeting Stage 2 meaningful use in electronic health record (EHR) products.
As the coming year approaches, more vendors are working toward meeting Stage 2 meaningful use in electronic health record (EHR) products.
“It has been a slow start. They’re working hard. They’re struggling a little bit,” said Alisa Ray, executive director and CEO of the Certification Commission for Health Information Technology, CCHIT. She adds that when comparing Stage 1 with Stage 2 certification, vendors are “navigating a higher bar and increased complexity.”
The 3 areas that have been most challenging in achieving Stage 2 certification are clinical quality measures, interoperability, and automated measure calculation for reporting metrics. Ms Ray reports that while more than 2000 products are being certified, only around 20% have been completely processed through the requirements. “It’s a testament to how much harder it is,” she said.
With the head seat of the Office of the National Coordinator for Health Information Technology vacant, and with a worrisome timetable for vendors to meet Stage 2 requirements, some are considering the possibility of a delay in implementation.
“Stage 2 definitely ups the ante, and the 2014 requirements are pretty significant. I think a lot of vendors are trying to also develop things in parallel to keep up with different payment models, and ACOs, and different initiatives like ICD-10,”says Lauren Fifield, senior health policy advisor at Practice Fusion. “They’re trying to develop data analytics platforms and things like that. So I’m not terribly surprised. Come January or February, I think it’ll be more of a tell-tale sign.”
However, federal requirements to meet Stage 2 meaningful use in EHRs is an intelligent move for the healthcare industry—the more stringent benchmarks for providers and vendors will drive value and quality.
Around the Web
EHR MakersSurprised by Stage 2 Complexity [Government Health IT]
EHR Market in Flux as Stage 2 of Meaningful Use Approaches [EHR Intelligence]
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Machine Learning Model Predicts Hepatocellular Carcinoma Risk in Patients With MASLD
March 22nd 2024Machine learning models have potential for early identification of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) who are at risk of hepatocellular carcinoma.
Read More